03 October 2014 - Washington, D.C. - USAID’s Office of Health, Infectious Diseases and Nutrition has awarded a five-year, cooperative agreement (up to $525 million) to a coalition of partners to implement the agency’s global tuberculosis strategy.
The lead partner for the Challenge TB award is KNCV Tuberculosis Foundation. Other consortium partners include American Thoracic Society, FHI 360, IRD, International Union Against Tuberculosis and Lung Disease, Japan Anti-Tuberculosis Association, MSH, PATH and the World Health Organization (WHO). The period of performance for the award will be 30 September 2014 through 29 September 2019.
Challenge TB will align with the WHO post-2015 Global TB Strategy and the new (2015 - 2019) U.S. Government TB Strategy to focus on improving patient-centered quality TB services, building local capacity, and increasing the utilization of new innovations and technologies to move forward in the global fight against TB.
Challenge TB will have three main objectives:
The award will expand upon previous successful TB programs and further USAID’s global efforts to control TB and support national TB programs in countries most affected by the disease. Challenge TB will be available through USAID country missions and regional bureaus.